The first Phase 3 data for a custom cancer vaccine has raised questions about whether the potential new treatment is needed.

When the news arrived in August that what could be the first personalized mRNA cancer vaccine had succeeded in a late-stage ...

“This is the first step,” said Dr. Robert Vonderheide, president-elect of the American Association for Cancer Research and ...

The treatment is still experimental, but results from Moderna and Merck add scientific support for a vaccine-based approach ...

Children were twice as likely to begin and complete the HPV vaccine series at clinics that began recommending it at ages 9 ...

An experimental vaccine developed by Merck and Moderna could become the first vaccine of its kind used to treat cancer. Scientists hope it won’t be the last.

Around 150,000 doses have already been delivered under national programs, but over-the-counter vaccines are still lacking. Additional quantities are expected in November ...

Bacillus Calmette-Guerin (BCG), a vaccine widely used to prevent tuberculosis and treat bladder cancer, may also have properties that reduce the risk for dementia, according to new findings in a study ...

A fully computational immunoinformatics study has produced three multi-epitope mRNA vaccine candidates against Rift Valley ...

Navy Hospital Corpsman 2nd Class Adam Venezia administers a flu shot during a vaccine drive at Hancock Elementary School in ...

Health Secretary Robert F. Kennedy Jr. announced a department-wide effort Thursday to study and treat possible vaccine injuries, days after quietly unveiling it at the National Institutes of Health’s ...